Logo image of SHOT

SAFETY SHOT INC (SHOT) Stock Fundamental Analysis

NASDAQ:SHOT - Nasdaq - US48208F1057 - Common Stock - Currency: USD

0.2711  +0.01 (+4.59%)

Fundamental Rating

0

Overall SHOT gets a fundamental rating of 0 out of 10. We evaluated SHOT against 35 industry peers in the Personal Care Products industry. Both the profitability and financial health of SHOT have multiple concerns. SHOT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year SHOT has reported negative net income.
SHOT had a negative operating cash flow in the past year.
SHOT had negative earnings in each of the past 5 years.
SHOT had a negative operating cash flow in each of the past 5 years.
SHOT Yearly Net Income VS EBIT VS OCF VS FCFSHOT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

The Return On Assets of SHOT (-655.91%) is worse than 97.14% of its industry peers.
Industry RankSector Rank
ROA -655.91%
ROE N/A
ROIC N/A
ROA(3y)-332.79%
ROA(5y)-248.72%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SHOT Yearly ROA, ROE, ROICSHOT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 1K 2K

1.3 Margins

SHOT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SHOT Yearly Profit, Operating, Gross MarginsSHOT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K

More info and screens

0

2. Health

2.1 Basic Checks

SHOT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SHOT has been increased compared to 1 year ago.
Compared to 5 years ago, SHOT has more shares outstanding
SHOT has a worse debt/assets ratio than last year.
SHOT Yearly Shares OutstandingSHOT Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
SHOT Yearly Total Debt VS Total AssetsSHOT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

Based on the Altman-Z score of -36.76, we must say that SHOT is in the distress zone and has some risk of bankruptcy.
SHOT's Altman-Z score of -36.76 is on the low side compared to the rest of the industry. SHOT is outperformed by 97.14% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -36.76
ROIC/WACCN/A
WACC9.61%
SHOT Yearly LT Debt VS Equity VS FCFSHOT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10M -10M

2.3 Liquidity

SHOT has a Current Ratio of 0.44. This is a bad value and indicates that SHOT is not financially healthy enough and could expect problems in meeting its short term obligations.
SHOT has a worse Current ratio (0.44) than 94.29% of its industry peers.
SHOT has a Quick Ratio of 0.44. This is a bad value and indicates that SHOT is not financially healthy enough and could expect problems in meeting its short term obligations.
SHOT has a worse Quick ratio (0.40) than 91.43% of its industry peers.
Industry RankSector Rank
Current Ratio 0.44
Quick Ratio 0.4
SHOT Yearly Current Assets VS Current LiabilitesSHOT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

2

3. Growth

3.1 Past

SHOT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -34.64%.
SHOT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -72.29%.
The Revenue has been growing by 134.03% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-34.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.73%
Revenue 1Y (TTM)-72.29%
Revenue growth 3Y-37.53%
Revenue growth 5Y134.03%
Sales Q2Q%-75.34%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SHOT Yearly Revenue VS EstimatesSHOT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2M 4M 6M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SHOT. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SHOT Price Earnings VS Forward Price EarningsSHOT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SHOT Per share dataSHOT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SHOT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SAFETY SHOT INC

NASDAQ:SHOT (6/6/2025, 3:42:09 PM)

0.2711

+0.01 (+4.59%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)05-15 2025-05-15
Earnings (Next)08-12 2025-08-12
Inst Owners7.94%
Inst Owner ChangeN/A
Ins Owners17.09%
Ins Owner Change-0.17%
Market Cap20.38M
AnalystsN/A
Price TargetN/A
Short Float %4.19%
Short Ratio1.7
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 27.39
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.97
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.23
FCFYN/A
OCF(TTM)-0.23
OCFYN/A
SpS0.01
BVpS-0.01
TBVpS-0.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -655.91%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-332.79%
ROA(5y)-248.72%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.44
Quick Ratio 0.4
Altman-Z -36.76
F-Score2
WACC9.61%
ROIC/WACCN/A
Cap/Depr(3y)373.12%
Cap/Depr(5y)254.13%
Cap/Sales(3y)387.51%
Cap/Sales(5y)234.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-34.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.73%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-72.29%
Revenue growth 3Y-37.53%
Revenue growth 5Y134.03%
Sales Q2Q%-75.34%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-81.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-237.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-235.81%
OCF growth 3YN/A
OCF growth 5YN/A